Capricor Therapeutics is anticipated to see limited growth i...
Capricor Therapeutics is anticipated to see limited growth in the future, keeping its P/S ratio low. Despite recent growth, its muted future outlook compared to the overall industry could remain a barrier for its share price.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3152Followers
0Following
7905Visitors
Follow